Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 3111-3121

  Doherty, T Mark ^a   Olsen, Anja Weinrich ^a   Van Pinxteren, Laurens ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHOLERA TOXIN; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; PHOSPHORYL LIPID A; RECOMBINANT VACCINE; SUBUNIT VACCINE;

AEROSOL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BCG VACCINATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNIZATION; INFECTION; LYMPHOCYTE CULTURE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BCG VACCINE; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; GUINEA PIGS; IMMUNIZATION, SECONDARY; INJECTIONS, SUBCUTANEOUS; LIPID A; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; TUBERCULOSIS, PULMONARY; VACCINATION; VACCINES, SYNTHETIC;

EID: 0036263333     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.3111-3121.2002     Document Type: Article

References (36)

1. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
2. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
3. TB vaccines: Progress and problems
4. Global tuberculosis control
5. Global tuberculosis programme and global programme on vaccines: Statement on BCG revaccination for the prevention of tuberculosis
6. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii
7. Strategies for mucosal vaccine development
8. ESAT-6 subunit vaccination against Mycobacterium tuberculosis
9. Failure of the Mycobacterium boris BCG vaccine: Some species of environmental mycobaeteria block multiplication of BCG and induction of protective immunity to tuberculosis
10. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Metaanalyses of the published literature
11. Mucosal immunity and tolerance: Relevance to vaccine development
12. What are the limits of adjuvanticity?
13. The innate immune response of the respiratory epithelium
14. Tuberculosis vaccine development
15. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
16. Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection
17. Variation in protection by BCG: Implications of and for heterologous immunity
18. Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains
19. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice
20. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation
21. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
22. Routine vaccinations and child survival: Follow up study in Guinea-Bissau, West Africa
23. Adjuvant modulation of immune responses to tuberculosis subunit vaccines
24. Modulation of immune responses following antigen administration by mucosal route
25. Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis?
26. Vaccination strategies for mucosal immune responses
27. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
28. Tuberculosis vaccine development: Recent progress
29. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo
30. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation
31. Toll-like receptors control activation of adaptive immune responses
32. Advances in vaccine adjuvants
33. Does BCG vaccine prevent tuberculous meningitis?
34. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
35. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance
36. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria